1. 1. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14: 1385-413.
2. 2. Shin HW, Kim YN, Bae HJ, et al. Trends in oral anticoagulation therapy among Korean patients with atrial fibrillation: The KORean Atrial Fibrillation Investigation. Korean Circ J 2012; 42: 113-7.
3. 3. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham heart study. JAMA 1994; 271: 840-4.
4. 4. Køber L, Swedberg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006; 8: 591-8.
5. 5. Hamaguchi S, Yokoshiki H, Kinugawa S, et al. Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 2009; 73: 2084-90.